Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUCA1 | P04066 | 2/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | LGALS8 | O00214 | 4/20 | 0.32 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.32 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.32 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | GBA1 | P04062 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 2/20 | 0.31 |
| ▸ | CA9 | Q16790 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13822005 | 1.00 | FUCA1 (0.52) | FUCA1L3MBTL1ALDH1A1TSHRLMNA | |
| SCHEMBL154476 | 1.00 | FUCA1 (0.52) | FUCA1L3MBTL1ALDH1A1TSHRLMNA | |
| SCHEMBL6534721 | 1.00 | FUCA1 (0.52) | FUCA1L3MBTL1ALDH1A1TSHRLMNA | |
| SCHEMBL12205165 | 1.00 | FUCA1 (0.52) | FUCA1L3MBTL1ALDH1A1TSHRLMNA | |
| SCHEMBL7948561 | 1.00 | FUCA1 (0.52) | FUCA1L3MBTL1ALDH1A1TSHRLMNA | |
| SCHEMBL12921945 | 1.00 | FUCA1 (0.52) | FUCA1L3MBTL1ALDH1A1TSHRLMNA | |
| SCHEMBL423526 | 1.00 | FUCA1 (0.52) | FUCA1L3MBTL1ALDH1A1TSHRLMNA | |
| SCHEMBL20844917 | 1.00 | FUCA1 (0.52) | FUCA1L3MBTL1ALDH1A1TSHRLMNA | |
| SCHEMBL22472219 | 1.00 | FUCA1 (0.52) | FUCA1L3MBTL1ALDH1A1TSHRLMNA | |
| SCHEMBL31384230 | 1.00 | FUCA1 (0.52) | FUCA1L3MBTL1ALDH1A1TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230203087-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | WAVE LIFE SCIENCES LTD. (SG) | 2023-06-29 | — | — | US | disclosed |
| US-20120016004-A1 | COMPOSITIONS FOR INHIBITING GENE EXPRESSION AND USES THEREOF | IDERA PHARMACEUTICALS, INC. | 2012-01-19 | — | — | US | disclosed |
| WO-2010039137-A1 | IMMUNE REGULATORY OLIGONUCLEOTIDE (IRO) COMPOUNDS TO MODULATE TOLL-LIKE RECEPTOR BASED IMMUNE RESPONSE | IDERA PHARMACEUTICALS, INC. (US) | 2010-04-08 | — | — | WO | disclosed |
| WO-2009014887-A2 | STABILIZED IMMUNE MODULATORY RNA (SIMRA) COMPOUNDS | IDERA PHARMACEUTICALS, INC. (US) | 2009-01-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120016004-A1 | COMPOSITIONS FOR INHIBITING GENE EXPRESSION AND USES THEREOF | RNGTT, NSUN2, RTCB | FUCA1 642/4885L3MBTL1 11/4885ALDH1A1 2452/4885 |
| US-20230203087-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | RNGTT, NSUN2, ALKBH1 | FUCA1 457/4885L3MBTL1 490/4885ALDH1A1 1901/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.